Aptevo Therapeutics (APVO) Earnings
|
Expand Research on APVO
| Next EPS Date | 8/6/26 | EPS Growth Rate | +35.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +27.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$5.39 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$3.78 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 | Q225 | -$8.40 | $0.00 | -$8.40 | N/A | N/A | N/A |  | | Details | |
| 11/7/24 | Q324 | -$0.48 | $0.00 | -$0.48 | N/A | N/A | N/A | | | Details | |
| 5/9/24 | Q124 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/24 | Q423 | N/A | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/9/23 | Q323 | N/A | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A |
